Pulmonary arterial hypertension

May 21, 2019

FDA approves Fragmin- an anticoagulant for children   The FDA today approved Fragmin for the treatment of blood clots. Pfizer’s candidate Fragmin which was earlier approved for the treatment of only adults suffering from a fatal disease called VTE, which can include deep vein thrombosis (blood clot in the d...

May 17, 2019

Pulmonary Arterial Hypertension (PAH) is a chronic, life-alarming disease that advances over time. It is a rare disease characterized by the increased blood pressure in the arteries of the lungs. It is somehow different from normal high pressure in a way that blood pressure rises only in the arteries that carry blo...

May 17, 2019

World Hypertension Day The World Hypertension day is celebrated on May 17, 2019. The theme is Know Your Numbers with the aim to increase awareness of high blood pressure (BP) around the world and promote hypertension prevention, detection and control. Cardiovascular diseases occur due to high blood pre...

Jun 03, 2015

Drugs with better pharmacodymics and improved treatment algorithm with antiproliferative and anti-inflammatory treatments are needed! Pulmonary arterial hypertension (PAH) is rare lung disorder affecting pulmonary arteries. It is a fatal disease associated with the vasoconstriction and vascular remodeling that i...